The Martha Transformation: A Deep Dive into Medtronic’s 2026 PivotAs of April 3, 2026, Medtronic plc (
NYSE: MDT) stands at a critical inflection point in its 77-year history. Once viewed as a lumbering healthcare conglomerate burdened by its own scale, the Dublin-based medical technology giant is currently navigating the final stages of a profound structural transformation. With the recent partial IPO of its diabetes [...]
